Enjoy complimentary customisation on priority with our Enterprise License!
The aptamers market share is expected to increase by USD 1.31 billion from 2021 to 2026, and the market's growth momentum will accelerate at a CAGR of 27.70%.
This aptamers market research report provides valuable insights on the post COVID-19 impact on the market, which will help companies evaluate their business approaches. Furthermore, this report extensively covers aptamers market segmentation by application (therapeutics development, research and development, diagnostic, and others) and geography (North America, Europe, Asia, and ROW). The aptamers market report also offers information on several market vendors, including Aptagen LLC, Aptamer Group Ltd., Aptamer Sciences Inc, APTATARGETS SL, Base Pair Biotechnologies Inc., Kaneka Corp., Maravai LifeSciences Holdings Inc., NeoVentures Biotechnology Inc, SomaLogic Inc, and Vivonics Inc among others.
Download the Free Report Sample to Unlock the Aptamers Market Size for the Forecast Period and Other Important Statistics
The increasing incidence of cancer boosting demand for novel diagnostics is notably driving the aptamers market growth, although factors such as inherent challenges associated with oligonucleotide therapies may impede market growth. Our research analysts have studied the historical data and deduced the key market drivers and the COVID-19 pandemic impact on the aptamers industry. The holistic analysis of the drivers will help in deducing end goals and refining marketing strategies to gain a competitive edge.
Key Aptamers Market Driver
The prevalence of chronic diseases such as cancer, cardiovascular diseases (CVD), diabetes, and autoimmune diseases is growing due to factors such as the increase in pollution and the adoption of a sedentary lifestyle. The growing incidence of cancer has increased the need for novel therapeutics. To accurately detect cancer cells, diagnostic tests primarily rely on antibody-antigen binding assays, which may have a few limitations, such as the inability to detect minor antibodies. Aptamers are better probes than monoclonal antibodies (mAbs). Aptamers are short single-stranded deoxyribonucleic acid (ssDNA) or ribonucleic acid (RNA) oligonucleotides, which recognize the target with high specificity and sensitivity. Unlike mAbs, which are stable only at low temperatures, aptamers are stable at ambient temperatures. Aptamers can be produced in vitro and are cost-effective compared to mAbs, which require animal hosts. Thus, aptamers can have high selectivity, affinity, and stability, and they can be used as molecular probes in bioanalysis and biomedicine. Hence, the rising prevalence of chronic and infectious diseases increases the demand for novel therapies, thus benefiting the global aptamers market.
Key Aptamers Market Challenge
Oligonucleotide therapy has the potential to improve biomedical research. Its applications are primarily in academic research and are projected to be promising in publications. However, the lack of transitional research dealing with real-world medical and scientific challenges affects the market. In several publications, oligonucleotide applications include single-cell mRNA that can act as potential therapeutic agents. However, the translation of this technology from academia to industry is yet to be explored. Another challenge is the administration of RNA-based drugs. RNAi and antisense molecules can be administered by intravenous or other similar methods. As these therapeutics cannot be administered orally, doctors or registered nurses must administer these drugs. In addition, errors in administration can lead to serious health concerns as non-specific mRNA may be targeted. These challenges will affect the adoption of aptamers.
This aptamers market analysis report also provides detailed information on other upcoming trends and challenges that will have a far-reaching effect on the market growth. The actionable insights on the trends and challenges will help companies evaluate and develop growth strategies for 2022-2026.
The report analyzes the market's competitive landscape and offers information on several market vendors, including:
This statistical study of the aptamers market encompasses successful business strategies deployed by the key vendors. The aptamers market is fragmented and the vendors are deploying various organic and inorganic growth strategies to compete in the market.
To make the most of the opportunities and recover from post COVID-19 impact, market vendors should focus more on the growth prospects in the fast-growing segments, while maintaining their positions in the slow-growing segments.
The aptamers market forecast report offers in-depth insights into key vendor profiles. The profiles include information on the production, sustainability, and prospects of the leading companies.
For more insights on the market share of various regions Request for a FREE sample now!
49% of the market's growth will originate from North America during the forecast period. The US and Canada are the key markets for aptamers in North America. However, the market growth rate in this region will be slower than the growth of the market in Asia and Europe.
The presence of a well-established healthcare system and high investments in healthcare research and testing will facilitate the aptamers market growth in North America over the forecast period. This market research report entails detailed information on the competitive intelligence, marketing gaps, and regional opportunities in store for vendors, which will assist in creating efficient business plans.
To gain further insights on the market contribution of various segments Request for a FREE sample
The aptamers market share growth by the therapeutics development segment will be significant due to the increasing number of clinical trials evaluating aptamers for new therapies and collaborations among vendors of aptamers and prominent pharmaceutical and biotechnology companies. For most therapeutic purposes, aptamers are truncated to reduce synthesis costs, modified at the sugars and capped at their termini to increase nuclease resistance, and conjugated to polyethylene glycol or another entity to reduce renal filtration rates.
This report provides an accurate prediction of the contribution of all the segments to the growth of the aptamers market size and actionable market insights on post COVID-19 impact on each segment.
Aptamers Market Scope |
|
Report Coverage |
Details |
Page number |
120 |
Base year |
2021 |
Forecast period |
2022-2026 |
Growth momentum & CAGR |
Accelerate at a CAGR of 27.70% |
Market growth 2022-2026 |
$ 1.31 billion |
Market structure |
Fragmented |
YoY growth (%) |
26.68 |
Regional analysis |
North America, Europe, Asia, and ROW |
Performing market contribution |
North America at 49% |
Key consumer countries |
US, Germany, UK, Canada, and China |
Competitive landscape |
Leading companies, Competitive strategies, Consumer engagement scope |
Key companies profiled |
Aptagen LLC, Aptamer Group Ltd., Aptamer Sciences Inc, APTATARGETS SL, Base Pair Biotechnologies Inc., Kaneka Corp., Maravai LifeSciences Holdings Inc., NeoVentures Biotechnology Inc, SomaLogic Inc, and Vivonics Inc |
Market dynamics |
Parent market analysis, Market growth inducers and obstacles, Fast-growing and slow-growing segment analysis, COVID-19 impact and recovery analysis and future consumer dynamics, Market condition analysis for the forecast period |
Customization purview |
If our report has not included the data that you are looking for, you can reach out to our analysts and get segments customized. |
We can help! Our analysts can customize this report to meet your requirements. Get in touch
Executive Summary
Market Landscape
Market Sizing
Five Forces Analysis
Market Segmentation by Application
Customer landscape
Geographic Landscape
Vendor Landscape
Vendor Analysis
Appendix
Get lifetime access to our
Technavio Insights
Cookie Policy
The Site uses cookies to record users' preferences in relation to the functionality of accessibility. We, our Affiliates, and our Vendors may store and access cookies on a device, and process personal data including unique identifiers sent by a device, to personalise content, tailor, and report on advertising and to analyse our traffic. By clicking “I’m fine with this”, you are allowing the use of these cookies. Please refer to the help guide of your browser for further information on cookies, including how to disable them. Review our Privacy & Cookie Notice.